AC Immune (ACIU) Debt Ratio (2017 - 2020)

AC Immune (ACIU) posted quarterly Debt Ratio of 0.0 for Q4 2020, down 100.1% year-over-year from 2.18 in Q1 2020, and down 278.22% quarter-over-quarter from 0.0 in Q3 2020.

AC Immune (ACIU) Debt Ratio (2017 - 2020) Analysis & Trends

AC Immune (ACIU) has reported Debt Ratio for 4 consecutive years, with 0.0 the latest figure, recorded in Q4 2020.

  • In Q4 2020, Debt Ratio fell 100.1% year-over-year to 0.0; the TTM figure through Dec 2020 stood at 0.0 (down 100.1% YoY), while the FY2020 annual figure was 0.0, down 100.1% from the prior year.
  • Debt Ratio retreated to 0.0 in Q4 2020 per ACIU's latest filing, from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 2.18 in Q4 2019 and bottomed at 0.0 in Q4 2020.
  • Historically, Debt Ratio has averaged 0.22 across 4 years, with a median of 0.0 in 2020.
  • On a YoY basis, Debt Ratio climbed as much as 59482999.56% in 2020 and fell as far as 100.1% in 2020.
  • AC Immune's Debt Ratio stood at 0.0 in 2017, then dropped by 29.41% to 0.0 in 2018, then surged by 82574.2% to 2.18 in 2019, then sank by 100.1% to 0.0 in 2020.
  • Business Quant data shows ACIU's Debt Ratio at 0.0 in Q4 2020, 0.0 in Q3 2020, and 0.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 AC Immune 253.89 Mn 253.89 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 0.00
Sep 30, 2020 0.00
Jun 30, 2020 0.00
Mar 31, 2020 0.00
Dec 31, 2019 2.18
Sep 30, 2019 0.00
Jun 30, 2019 0.00
Mar 31, 2019 0.00
Dec 31, 2018 0.00
Dec 31, 2017 0.00